<DOC>
	<DOCNO>NCT01982565</DOCNO>
	<brief_summary>This 2 part study ass safety efficacy nitric oxide ( NOx ) generate dress chronic diabetic foot ulcer ( DFU ) . Nitric oxide range effect body include vasodilation angiogenesis . It also potent antimicrobial . This 140 patient , randomise , control clinical study assess ability simple 2 part , NOx generate dress increase blood flow DFUs improve heal chronic DFUs compare standard care .</brief_summary>
	<brief_title>Nitric Oxide Generating Gel Dressing Patients With Diabetic Foot Ulcers</brief_title>
	<detailed_description>This clinical study new wound dress diabetic foot ulcer ( DFU ) . The dressing consist 2 stable layer place together release Nitric Oxide . In preclinical study NOx delivery cause significant vasodilation , angiogenesis demonstrate potent anti-microbial activity . In part 1 study , dress apply 20 DFUs set period blood flow around wind measure application dress . Any adverse event record . If increase blood flow see dress well tolerate , part 2 begin , multi-centre , 120 patient , randomise , control study . 60 patient chronic DFUs treat NOx generate dress 60 patient continue receive standard care . The efficacy tolerability dress measure . The NOx dress change least every 2 day standard care change normal clinical practice . At weekly clinical visit diameter , area volume wound measure . The infective status wound assess inflammatory profile wound measure .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Male female patient age 18 year . Diagnosed type 1 type 2 diabetes . With chronic ( present least 6 week ) fullthickness foot ulcer ( malleoli ) penetrate tendon , periosteum bone , crosssectional area 25 2500 mm2 . Patients must pedal blood flow normal moderately ischaemic . Measurable palpable pedal pulse absence palpable pedal pulse must TcPO2 â‰¥30mmHg ABPI 0.51.00 , &gt; 1.2 . ( An ABPI &gt; 1.2 associate calcification rather ischaemia . We include patient ABPI &gt; 1.2 ABPI measure large artery . NOx ability dilate medium small arteriole less likely calcify . ) With degree neuropathy ( commonly see Diabetes Foot Clinic ) . Able read understand Volunteer Information Sheet provide meaningful write informed consent . Able willing follow Protocol requirement . Female patient pregnant breastfeed Any serious disease likely compromise outcome trial Participation clinical study eight ( 8 ) week precede dose period study Wound area great 2500 square mm ; Patients severe ischaemia . Measurable absence palpable pedal pulse TcPO2 le 30mmhg , ABPI &lt; 0.5 1.01.2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Nitric oxide</keyword>
	<keyword>Nitric oxide dress</keyword>
	<keyword>NOx</keyword>
	<keyword>NOx dress</keyword>
	<keyword>Diabetic</keyword>
	<keyword>Foot</keyword>
	<keyword>Ulcers</keyword>
	<keyword>Chronic</keyword>
</DOC>